Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: To enhance post-transplantation hepatocellular carcinoma (HCC) recurrence prediction by ...
In recent times, chronic kidney cancer has been considered a significant cause of cancer, and Renal ...
BACKGROUND: Conventional diagnostic tools, including ultrasound, fine-needle aspiration cytology, an...
Nanorobotics is catalyzing a paradigm shift in GI surgery by synergizing nanoscale engineering, synt...
Renal cancer is amid the several reasons of increasing mortality rates globally, which can be reduce...
In this study, we proposed a lightweight neural network architecture based on inverted residual netw...
BACKGROUND: We aimed to explore the regulatory gene associated with O-GlcNAcylation in oral squamous...
Organ transplantation remains the sole definitive treatment for many forms of end-stage organ failur...
The 4-1BB receptor, a key member of the tumor necrosis factor receptor (TNFR) family, represents a h...
The immune response to tumour development is frequently targeted with therapeutics but remains large...
Helicobacter pylori (H. pylori) is the most common carcinogenic pathogen globally and the leading ca...
INTRODUCTION: Hepatoblastoma (HB) with hepatocellular carcinoma (HCC) features (HBHF) is a rare live...
Endocervical adenocarcinoma (ECA) the fatal and intrusive subtype of cervical carcinoma is on rise f...
Breast cancer remains the most prevalent cause of cancer-related mortality among women worldwide, wi...
Skin cutaneous melanoma (SKCM) is a fatal form of skin cancer. Metabolism-related genes (MRGs) compr...
Hilar cholangiocarcinoma (hCCA), a rare cancer of the biliary system, has a poor prognosis. This stu...
Colorectal cancer (CRC) exhibits substantial heterogeneity in molecular subtypes and clinical outcom...
The brain tumours originate in the brain or its surrounding structures, such as the pituitary and pi...
BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third m...
OBJECTIVES: No existing algorithm can reliably identify metastasis from pathology reports across mul...
BACKGROUND: Surgeons often face challenges in distinguishing between benign and malignant follicular...